Why the study?
Does routine measurement of FFR reduce the composite end point of death, nonfatal myocardial infarction, and repeat revascularization in patients with multivessel coronary artery disease undergoing PCI with drug-eluting stents?
Does routine measurement of FFR reduce the composite end point of death, nonfatal myocardial infarction, and repeat revascularization in patients with multivessel coronary artery disease undergoing PCI with drug-eluting stents?
Routine FFR guidance during PCI for multivessel coronary artery disease significantly improves 1-year clinical outcomes compared to angiography guidance alone.
Supports routine FFR guidance in multivessel PCI; extends randomized evidence favoring physiology over angiography alone.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tonino et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: